Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

Autor: Rawson NS, Adams J

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 721-730 (2017)

Nigel SB Rawson,1–3 John Adams4 1Eastlake Research Group, Oakville, ON, 2Canadian Health Policy Institute, Toronto, ON, 3Fraser Institute, Vancouver, BC, 4Canadian PKU and Allied Disorders Inc., Toronto, ON, Canada Abstract: In democratic societies

Externí odkaz: https://doaj.org/article/4ee8b50a70274c529c8500978a9bc3e5

PIH9 A SIMULATION MODELING OF THE EFFECT OF DOSING SCHEDULE ON THE BENEFIT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN CANADA

Autor: Ismaila, AS, Pereira, JA, Robson, RC, Rawson, NS, Simpson, SD, Standaert, BA

Publikováno v: In Value in Health 2009 12(3):A163-A163

The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health.

Autor: Balijepalli C; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Gullapalli L; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Joshy J; Pharmalytics Group, Vancouver, BC V6B 2Z4, Canada., Rawson NS; Canadian Health Policy Institute, Toronto, ON, Canada.; Macdonald-Laurier Institute, Ottawa, ON, Canada.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2024 May; Vol. 13 (5), pp. e230178. Date of Electronic Publication: 2024 Apr 03.

Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost.

Autor: Rawson NS; Eastlake Research Group, Oakville, ON, Canada. EastlakeRG@gmail.com.; Canadian Health Policy Institute, Toronto, ON, Canada. EastlakeRG@gmail.com.; Fraser Institute, Vancouver, BC, Canada. EastlakeRG@gmail.com.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2017 Mar 23; Vol. 12 (1), pp. 59. Date of Electronic Publication: 2017 Mar 23.

Health Canada's use of priority review status for drugs for unmet needs.

Autor: Rawson NS; Eastlake Research Group, Oakville, Ontario, Canada; Canadian Health Policy Institute, Toronto, Ontario, Canada. Electronic address: EastlakeRG@gmail.com.

Publikováno v: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2015 Oct; Vol. 73 (1), pp. 391-5. Date of Electronic Publication: 2015 Aug 08.